De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticity.

TUBA4A ataxia cerebellar atrophy de novo spasticity tubulinopathy

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
17 Jun 2024
Historique:
received: 28 01 2024
revised: 31 03 2024
accepted: 06 05 2024
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: aheadofprint

Résumé

Alpha-tubulin 4A encoding gene (TUBA4A) has been associated with familial amyotrophic lateral sclerosis (fALS) and fronto-temporal dementia (FTD), based on identification of likely pathogenic variants in patients from distinct ALS and FTD cohorts. By screening a multicentric French cohort of 448 unrelated probands presenting with cerebellar ataxia, we identified ultra-rare TUBA4A missense variants, all being absent from public databases and predicted pathogenic by multiple in-silico tools. In addition, gene burden analyses in the 100,000 genomes project (100KGP) showed enrichment of TUBA4A rare variants in the inherited ataxia group compared to controls (OR: 57.0847 [10.2- 576.7]; p = 4.02 x10-07). Altogether, we report 12 patients presenting with spasticity and/or cerebellar ataxia and harboring a predicted pathogenic TUBA4A missense mutation, including 5 confirmed de novo cases and a mutation previously reported in a large family presenting with spastic ataxia. Cultured fibroblasts from 3 patients harboring distinct TUBA4A missense showed significant alterations in microtubule organisation and dynamics, providing insight of TUBA4A variants pathogenicity. Our data confirm the identification of a hereditary spastic ataxia disease gene with variable age of onset, expanding the clinical spectrum of TUBA4A associated phenotypes.

Identifiants

pubmed: 38884572
pii: 7694334
doi: 10.1093/brain/awae193
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

J C Ambrose (JC)
P Arumugam (P)
E L Baple (EL)
M Bleda (M)
F Boardman-Pretty (F)
J M Boissiere (JM)
C R Boustred (CR)
H Brittain (H)
M J Caulfield (MJ)
G C Chan (GC)
C E H Craig (CEH)
L C Daugherty (LC)
A de Burca (A)
A Devereau (A)
G Elgar (G)
R E Foulger (RE)
T Fowler (T)
P Furió-Tarí (P)
J M Hackett (JM)
D Halai (D)
A Hamblin (A)
S Henderson (S)
J E Holman (JE)
T J P Hubbard (TJP)
K Ibáñez (K)
R Jackson (R)
L J Jones (LJ)
D Kasperaviciute (D)
M Kayikci (M)
L Lahnstein (L)
K Lawson (K)
S E A Leigh (SEA)
I U S Leong (IUS)
F J Lopez (FJ)
F Maleady-Crowe (F)
J Mason (J)
E M McDonagh (EM)
L Moutsianas (L)
M Mueller (M)
N Murugaesu (N)
A C Need (AC)
C A Odhams (CA)
C Patch (C)
D Perez-Gil (D)
D Polychronopoulos (D)
J Pullinger (J)
T Rahim (T)
A Rendon (A)
P Riesgo-Ferreiro (P)
T Rogers (T)
M Ryten (M)
K Savage (K)
K Sawant (K)
R H Scott (RH)
A Siddiq (A)
A Sieghart (A)
D Smedley (D)
K R Smith (KR)
A Sosinsky (A)
W Spooner (W)
H E Stevens (HE)
A Stuckey (A)
R Sultana (R)
E R A Thomas (ERA)
S R Thompson (SR)
C Tregidgo (C)
A Tucci (A)
E Walsh (E)
S A Watters (SA)
M J Welland (MJ)
E Williams (E)
K Witkowska (K)
S M Wood (SM)
M Zarowiecki (M)

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Mehdi Benkirane (M)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.
PhyMedExp Univ Montpellier, CNRS UMR 9214, INSERM U1046, 34090 Montpellier, France.
Department of Medical Genetics, Laboratory of Genomics Medicine, Sorbonne University, APHP, 75006 Paris, France.

Marion Bonhomme (M)

CRBM (Centre de Recherche en Biologie cellulaire de Montpellier), CNRS, Université de Montpellier, 34293 Montpellier, France.

Heba Morsy (H)

Department of Neuromuscular Diseases, UCL Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.
Human Genetics Department, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.

Stephanie L Safgren (SL)

Department of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.

Cecilia Marelli (C)

MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France; Expert center for Neurogenetic Diseases, CHU of Montpellier, 34095 Montpellier, France.

Annabelle Chaussenot (A)

Department of Medical Genetics, CHU of Nice, 06000 Nice, France.

Damian Smedley (D)

William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London EC1M 6BQ, UK.

Valentina Cipriani (V)

William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London EC1M 6BQ, UK.
UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
UCL Genetics Institute, University College London, London WC1E 6BT, UK.

Jean-Madeleine de Sainte-Agathe (JM)

Department of Medical Genetics, Laboratory of Genomics Medicine, Sorbonne University, APHP, 75006 Paris, France.

Can Ding (C)

Institute of human genetics, University of Medicine Mainz, Mainz 55128, Germany.

Lise Larrieu (L)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.

Letizia Vestito (L)

William Harvey Research Institute, Clinical Pharmacology and Precision Medicine, Queen Mary University of London, London EC1M 6BQ, UK.

Henri Margot (H)

Department of Medical Genetics, CHU of Bordeaux, 33404 Bordeaux, France.

Gaetan Lesca (G)

Department of Medical Genetics, University Hospitals of Lyon, and Université Claude Bernard Lyon1, 69500 Lyon, France.

Francis Ramond (F)

Department of Medical Genetics, CHU of Saint-Etienne, 42055 Saint-Etienne, France.

Anna Castrioto (A)

Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Neurology Department, 38706 Grenoble, France.

David Baux (D)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.
INM, Institut des Neurosciences Montpellier, INSERM, 34000 Montpellier, France.
Montpellier BioInformatics for Clinical Diagnosis (MOBIDIC), Molecular Medicine and Genomics Platform (PMMG), CHU Montpellier, 34295 Montpellier, France.

Jan Verheijen (J)

Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Emna Sansa (E)

Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Institute of Neurology, London WC1N 3BG, UK.

Paola Giunti (P)

Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Institute of Neurology, London WC1N 3BG, UK.

Aline Haetty (A)

INM, Institut des Neurosciences Montpellier, INSERM, 34000 Montpellier, France.

Anne Bergougnoux (A)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.
PhyMedExp Univ Montpellier, CNRS UMR 9214, INSERM U1046, 34090 Montpellier, France.

Morgane Pointaux (M)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.

Olivier Ardouin (O)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.
Montpellier BioInformatics for Clinical Diagnosis (MOBIDIC), Molecular Medicine and Genomics Platform (PMMG), CHU Montpellier, 34295 Montpellier, France.

Charles Van Goethem (C)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.
Montpellier BioInformatics for Clinical Diagnosis (MOBIDIC), Molecular Medicine and Genomics Platform (PMMG), CHU Montpellier, 34295 Montpellier, France.

Marie-Claire Vincent (MC)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.

Marios Hadjivassiliou (M)

Academic Department of Neurosciences, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2HQ, UK.

Mireille Cossée (M)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.
PhyMedExp Univ Montpellier, CNRS UMR 9214, INSERM U1046, 34090 Montpellier, France.

Tiphaine Rouaud (T)

Department of Neurology, CHU of Nantes, 44000 Nantes, France.

Oliver Bartsch (O)

Institute of human genetics, University of Medicine Mainz, Mainz 55128, Germany.

William D Freeman (WD)

Department of Neurology, Mayo Clinic Jacksonville, FL 32224, USA.

Klaas J Wierenga (KJ)

Department of Clinical Genomics, Mayo Clinic, Jacksonville, FL 32224, USA.

Eric W Klee (EW)

Department of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA.
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.

Jana Vandrovcova (J)

Department of Neuromuscular Diseases, UCL Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.

Henry Houlden (H)

Department of Neuromuscular Diseases, UCL Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK.

Anne Debant (A)

CRBM (Centre de Recherche en Biologie cellulaire de Montpellier), CNRS, Université de Montpellier, 34293 Montpellier, France.

Michel Koenig (M)

Laboratoire de Génétique moléculaire, Institut Universitaire de Recherche Clinique, CHU of Montpellier, 34090 Montpellier, France.
PhyMedExp Univ Montpellier, CNRS UMR 9214, INSERM U1046, 34090 Montpellier, France.

Classifications MeSH